Back to Search
Start Over
45P Long-term efficacy of neratinib in HER2-positive early-stage breast cancer: Overall survival and central nervous system outcomes from the phase III ExteNET trial.
- Source :
-
Annals of Oncology . 2021 Supplement 2, Vol. 32, pS40-S40. 1p. - Publication Year :
- 2021
- Subjects :
- *BREAST cancer treatment
*PROTEIN-tyrosine kinase inhibitors
*DRUG efficacy
Subjects
Details
- Language :
- English
- ISSN :
- 09237534
- Volume :
- 32
- Database :
- Academic Search Index
- Journal :
- Annals of Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 152686151
- Full Text :
- https://doi.org/10.1016/j.annonc.2021.03.059